Calypte's HIV-1 Urine Test Approved for Use in People's Republic of China
(ALAMEDA, CA) Calypte Biomedical Corporation has announced that the State Drug Administration of the People's Republic of China (PRC) has approved its HIV-1 antibody urine test. According to the Joint Nations Programme on HIV/AIDS, half a million Chinese citizens are currently infected with the HIV virus. Left unchecked, officials of the Chinese National Center for AIDS Prevention and Control (NCAIDS) estimate that the total number of HIV infections in China could reach 10 million before 2010. Earlier this year, Calypte announced that it had partnered with NCAIDS through Beijing HuaAi Science and Technology Development Co. Ltd. to distribute the HIV-1 urine test within the PRC. For more information visit www.calypte.com.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
